ctrl K

Price Alert

Bicycle Therapeutics (BCYC)

NASDAQ: BCYC · Real-Time Price · USD

7.16

0.19 (2.73%)

At close: Sep 05, 2025, 3:59 PM

7.05

-1.54%

After-hours: Sep 05, 2025, 07:44 PM EDT

Bicycle Therapeutics Revenue Breakdown

Period Ending	Sep 30, 2021
Target 6 Material Right Revenue	1.1M
Target 6 Material Right Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017
Selling, General, and Administrative Revenue	19.24M	20.92M	21.02M	18.26M	17.71M	15.13M	15.05M	15.57M	15.18M	14.49M	10.68M	10.25M	11.82M	16.85M	8.84M	8.27M	7.35M	8.14M	10.85M	7.15M	6.2M	5M	3.4M	4.79M	2.97M	3.4M	2.11M	2.33M	1.7M	1.99M	2.57M
Selling, General, and Administrative Revenue Growth	-8.06%	-0.46%	+15.14%	+3.10%	+17.03%	+0.53%	-3.31%	+2.56%	+4.76%	+35.69%	+4.20%	-13.34%	-29.81%	+90.52%	+6.94%	+12.55%	-9.74%	-24.99%	+51.66%	+15.46%	+23.97%	+47.17%	-29.09%	+61.08%	-12.61%	+61.54%	-9.42%	+36.60%	-14.39%	-22.65%	n/a
Research and Development Revenue	71.03M	59.06M	49.78M	48.27M	47.42M	50.18M	44.7M	39.87M	39.72M	32.21M	24.72M	22.75M	19.85M	14.28M	12.95M	10.51M	11.72M	9.69M	10.06M	7.36M	7.96M	7.77M	6.65M	6.08M	6.54M	6.28M	6.49M	5.64M	4.92M	3.71M	6.98M
Research and Development Revenue Growth	+20.27%	+18.64%	+3.13%	+1.78%	-5.50%	+12.27%	+12.11%	+0.37%	+23.31%	+30.31%	+8.65%	+14.60%	+38.99%	+10.28%	+23.20%	-10.31%	+20.93%	-3.62%	+36.59%	-7.48%	+2.37%	+16.92%	+9.39%	-7.02%	+4.16%	-3.34%	+15.08%	+14.74%	+32.57%	-46.85%	n/a